Inactivating mutations in ARID1A have been identified in a wide variety of malignancies (Wiegand et al., 2010; Guichard et al., 2012; Wang et al., 2015), suggesting that it functions as a tumor suppressor. Here, ARID1A is linked to neoplasm.